ADVFN - Advanced Financial Network.
HOME» NYSE » A » ABT Stock Price » ABT Stock News

Abbott Labs Share News

 Abbott Laboratories Stock Price
ABT Stock Price
 Abbott Laboratories Stock Chart
ABT Stock Chart
 Abbott Laboratories Stock News
ABT Stock News
 Abbott Laboratories Company Information
ABT Company Information
 Abbott Laboratories Stock Trades
ABT Stock Trades

Abbott India Names Rehan Khan Managing Director

BANGALORE -(Dow Jones)- Abbott India Ltd. (500488.BY) said Rehan Khan has been appointed as the company's managing director, effective Thursday. Khan is currently general manager and country head of Abbott Nutrition, India, a position he has held since 2009, the Indian unit of Abbott Laboratories (ABT) said in a statement. Khan replaces Vivek Mohan, who has been named senior director, global integrated health, established pharmaceuticals division, at Abbott. Mohan will report to Michael Warmuth, senior vice president, established pharmaceuticals division, at Abbott. -By Rumman Ahmed, Dow Jones Newswires; 91-9845104173; [email protected]

Stock News for Abbott Labs (ABT)
DateTimeHeadline
01/13/201702:19:08Aqua Bio Technology enters new technology partnership
01/12/201716:00:00Abbott Announces U.S. Launch and First Commercial Use of the...
01/12/201704:01:29Aqua Bio Technology enters into New Zealand partnership
01/12/201702:50:32Aqua Bio Technology expands product portfolio
01/11/201702:00:31ABT expands business model
01/10/201707:00:00Abbott Announces CE Mark for its Alinity ci-series Diagnostic...
01/10/201707:00:00Abbott Announces CE Mark for its "Alinity s" Blood and Plasma...
01/10/201707:00:00Abbott Announces CE Mark for its Alinity ci-series Diagnostic...
01/10/201707:00:00Abbott Announces CE Mark for its "Alinity s" Blood and Plasma...
01/09/201717:33:00Abbott's St. Jude Patches Device Software After Regulators Confirm...
01/08/201715:11:00Parkinson's Therapy Gets Fresh Look From Device Makers
01/08/201715:10:00Parkinson's Therapy Gets Fresh Look From Device Makers
01/08/201707:29:00Parkinson's Therapy Gets Fresh Look From Device Makers
01/06/201717:30:20Statement of Changes in Beneficial Ownership (4)
01/06/201717:30:20Statement of Changes in Beneficial Ownership (4)
01/06/201717:27:47Initial Statement of Beneficial Ownership (3)
01/06/201717:27:21Initial Statement of Beneficial Ownership (3)
01/06/201717:08:28Statement of Changes in Beneficial Ownership (4)
01/05/201716:25:11Current Report Filing (8-k)
01/04/201717:08:00Statement of Changes in Beneficial Ownership (4)

Abbott Laboratories and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US